Freestone Grove Partners LP Celcuity Inc. Transaction History
Freestone Grove Partners LP
- $13.4 Trillion
- Q3 2025
A detailed history of Freestone Grove Partners LP transactions in Celcuity Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 10,000 shares of CELC stock, worth $924,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$924,400% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CELC
# of Institutions
162Shares Held
36MCall Options Held
539KPut Options Held
191K-
Baker Bros. Advisors LP New York, NY7.92MShares$732 Million3.17% of portfolio
-
Perceptive Advisors LLC New York, NY2.96MShares$273 Million0.32% of portfolio
-
Nea Management Company, LLC Timonium, MD2.14MShares$198 Million6.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$190 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.51MShares$140 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $1.38B
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...